VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,581,176 | $60,838,000 | 4.05% |
| ARMISTICE CAPITAL, LLC | 3,548,000 | $47,117,000 | 3.12% |
| Birchview Capital, LP | 80,000 | $1,062,000 | 0.71% |
| 361 CAPITAL LLC | 163,333 | $2,169,000 | 0.40% |
| CADENCE CAPITAL MANAGEMENT LLC | 172,512 | $2,291,000 | 0.32% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 215,936 | $2,868,000 | 0.25% |
| Zebra Capital Management LLC | 15,634 | $208,000 | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 149,139 | $1,981,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 48,207 | $640,000 | 0.14% |
| Virtus ETF Advisers LLC | 47,470 | $630,000 | 0.13% |